Journal
PHARMACEUTICS
Volume 13, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13101637
Keywords
ophthalmic inserts; drug-loaded; nanofibers; electrospinning
Categories
Ask authors/readers for more resources
Nanofiber-based ocular inserts have shown success in targeting drug delivery and improving bioavailability for treating anterior and posterior eye diseases. A systematic review of recent studies and patents has highlighted the potential of these innovative ocular inserts for enhancing drug efficacy in ophthalmic treatments.
Currently, ocular inserts and nanoparticles have received much attention due to the limited bioavailability of conventional eye preparations and the toxicity problems of systemic drug administration. The current systematic review aims to present recent studies on the use of electrospun nanofiber-based ocular inserts to improve the bioavailability of drugs used for different ophthalmic diseases. A systematic search was performed in PubMed, Ovid Medline, Web of Science, ScienceDirect, Scopus, Reaxys, Google Scholar, and Google Patents/Espacenet taking drug-loaded , nanofibers , and ophthalmic inserts and their equivalent terms as keywords. The search was limited to original and peer-reviewed studies published in 2011-2021 in English language. Only 13 out of 795 articles and 15 out of 197 patents were included. All results revealed the success of nanofiber-based ocular inserts in targeting and improved bioavailability. Ocular inserts based on nanofibers can be used as safe, efficient carriers for the treatment of anterior and posterior eye diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available